-
公开(公告)号:EP4067371A1
公开(公告)日:2022-10-05
申请号:EP21166438.8
申请日:2021-03-31
申请人: Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft , Charité - Universitätsmedizin Berlin
IPC分类号: C07K14/435
摘要: The invention is based on antigen binding proteins (ABPs) such as T-cell receptors (TCR) expressed on T-cells, which have a specificity to bind to MHC presented Hepatitis C Virus peptides. Provided are isolated ABPs as well as genetic constructs expressing the ABPs, recombinant host cells harboring the ABP of the invention and methods for producing such ABPs and host cells. Moreover, provided are medical applications involving the TCR of the invention, for example in context of an adoptive T-cell therapy.